XML 73 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
6 Months Ended
Jun. 30, 2014
SEGMENT INFORMATION  
SEGMENT INFORMATION

NOTE 13 — SEGMENT INFORMATION

 

The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing solutions.  The Company is organized into three reporting segments.  Operations that sell dispensing systems primarily to the personal care, beauty and home care markets form the Beauty + Home segment.  Operations that sell dispensing systems primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment.  Operations that sell dispensing systems primarily to the food and beverage markets form the Food + Beverage segment.

The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.  Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and related depreciation and income taxes.

 

Financial information regarding the Company’s reportable segments is shown below:

 

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

Total Revenue:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

391,215

 

$

378,828

 

$

789,755

 

$

746,011

 

Pharma

 

195,690

 

182,995

 

390,039

 

351,888

 

Food + Beverage

 

90,192

 

83,570

 

180,818

 

168,903

 

Total Revenue

 

677,097

 

645,393

 

1,360,612

 

1,266,802

 

Less: Intersegment Sales:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

5,989

 

$

3,844

 

$

13,293

 

$

7,555

 

Pharma

 

--

 

64

 

--

 

88

 

Food + Beverage

 

477

 

44

 

637

 

85

 

Total Intersegment Sales

 

$

6,466

 

$

3,952

 

$

13,930

 

$

7,728

 

Net Sales:

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

385,226

 

$

374,984

 

$

776,462

 

$

738,456

 

Pharma

 

195,690

 

182,931

 

390,039

 

351,800

 

Food + Beverage

 

89,715

 

83,526

 

180,181

 

168,818

 

Net Sales

 

$

670,631

 

$

641,441

 

$

1,346,682

 

$

1,259,074

 

 

 

 

 

 

 

 

 

 

 

Segment Income (1):

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

27,198

 

$

30,339

 

$

54,979

 

$

54,754

 

Pharma

 

52,793

 

50,437

 

105,275

 

96,417

 

Food + Beverage

 

12,416

 

11,864

 

21,496

 

20,414

 

Restructuring Initiatives and Related Depreciation

 

--

 

(3,067

)

--

 

(7,593

)

Corporate & Other

 

(8,502

)

(8,707

)

(20,300

)

(19,492

)

Income before interest and taxes

 

$

83,905

 

$

80,866

 

$

161,450

 

$

144,500

 

Interest expense, net

 

(4,199

)

(4,596

)

(8,064

)

(8,828

)

Income before income taxes

 

$

79,706

 

$

76,270

 

$

153,386

 

$

135,672

 

 

(1)     The Company evaluates performance of our business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes. Restructuring Initiatives and Related Depreciation includes the following income/(expense) items for the three and six months ended June 30, 2014 as follows:

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

2014

 

2013

 

2014

 

2013

 

 

 

 

 

 

 

 

 

 

 

European Operations Optimization (“EOO”) Plan

 

 

 

 

 

 

 

 

 

Depreciation

 

$

--

 

$

556

 

$

--

 

$

1,015

 

Employee Severance and Other Costs

 

--

 

2,555

 

--

 

6,622

 

Prior Year Initiatives

 

--

 

(44

)

--

 

(44

)

Total Restructuring Initiatives and Related Depreciation Expense

 

$

--

 

$

3,067

 

$

--

 

$

7,593

 

 

 

 

 

 

 

 

 

 

 

Restructuring Initiatives and Related Depreciation Expense by Segment

 

 

 

Beauty + Home

 

$

--

 

$

3,090

 

$

--

 

$

7,616

 

Pharma

 

--

 

--

 

--

 

--

 

Food + Beverage

 

--

 

(23

)

--

 

(23

)

Total Restructuring Initiatives and Related Depreciation Expense

 

$

--

 

$

3,067

 

$

--

 

$

7,593